Home › Mutual Funds › Tata Mutual Fund › Tata India Pharma & Healthcare Fund Direct Payout of Inc Dist cum Cap Wdrl
Latest NAV & returns of TATA ASSET MANAGEMENT LTD.

Tata India Pharma & Healthcare Fund Direct Payout of Inc Dist cum Cap Wdrl

Add To Compare

previously known as Tata India Pharma & Healthcare Dir DP until

35.526 (-0.805%)
NAV on December 20, 2024
Category Equity:
Sector - Healthcare
Investment StyleBox
Large Growth
Total Assets 1,208 cr
Turnover Ratio 28.44%
Expense Ratio 0.69%
Exit Load 0.25%if redeemed within
30 Days0.00%if redeemed after 30 Days
Returns
  • 1M: 4.72%
  • 1Y: 44.44%
  • 3M: -0.22%
  • 3Y: 24.60%
  • 6M: 18.55%
  • 5Y: 29.31%
Min Investment 5,000
Buy Now Start SIP
ADDITIONAL INFO
Fund Manager Meeta Shetty (Since almost 4 years) Rajat Srivastava (Since 3 months)
ISIN INF277K011B8
Fund Family Tata
P/E Ratio 35.36
P/B Ratio 5.28
Launch Date December 28, 2015
Benchmark Nifty Pharma TR INR
ASSET ALLOCATION
EQUITY DISTRIBUTION
RISK MEASURES (3 yrs)
vs Nifty Pharma TR INR

Alpha 3.81
Beta 0.92
R-Squared 96.70
Info Ratio 1.14
Tracking Err 3.05
Sortino 2.042
Sharpe 1.006
Std Dev 15.146
Risk -
SECTOR WEIGHTINGS (%)
Financial 0.0%
Industrial 0.0%
Technology 0.0%
Basic Materials 2.27%
Consumer Cyclical 0.0%
Utilities Services 0.0%
Healthcare Services 97.73%
Energy Services 0.00%
Communication Services 0.00%
Consumer Defensive 0.00%
Real Estate 0.00%
INVESTMENT OBJECTIVE

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns.

This fund may declare and pay out a dividend to you on a periodic basis, but only when it has the profits to do so.

View Factsheet
-
Best Sector Healthcare Funds
NAME LATEST
NAV		 RETURNS
1y     		FUND
ASSETS		 Expense
RATIO		 RISK
Sbi
SBI Healthcare Opportunities Fund Direct Growth
488.549 43.91% 3,460 cr 0.89% -


Other plans of Tata India Pharma & Healthcare


Other Equity funds by Tata

Data Partner
Click here to visit AMC website and
read all scheme related documents Tata Fund